National expert consensus on home-administered oncologic therapies in Spain
Villegas, Eulalia (Hospital Dos de Maig (Barcelona, Catalunya))
Arruñada, María (Pharmacoeconomics and Outcomes Research Iberia (PORIB))
Casado, Miguel Ángel (Pharmacoeconomics and Outcomes Research Iberia (PORIB))
González, Sonia (Complexo Hospitalario Universitario de Vigo)
Moreno Martinez, Maria Estela (Institut de Recerca Sant Pau)
Peñuelas, María Ángeles (Hospital Universitari Vall d'Hebron)
Torres, Ana Maria (Hospital Dos de Maig (Barcelona, Catalunya))
Sierra, Yanik (Eisai Farmaceutica SA)
Seguí, Miguel Angel (Universitat Autònoma de Barcelona. Departament de Medicina)

Data:	2024
Resum:	The diagnosis and treatment of cancer impose a significant emotional and psychological burden on patients, families, and caregivers. Patients undergo several interventions in a hospital setting, and the increasing number of patients requiring extended care and follow-up is driving the demand for additional clinical resources to address their needs. Hospital at Home (HaH) teams have introduced home-administered oncologic therapies that represent a new model of patient-centered cancer care. This approach can be integrated with traditional models and offers benefits to both patients and healthcare professionals (HCPs). Home-administered treatment programs have been successfully piloted globally, demonstrated as a preferred option for most patients and a safe alternative that could reduce costs and hospital burden. The document aims to establish the minimum recommendations for the home administration of oncologic therapies (ODAH) based on a national expert agreement. The expert panel comprised seven leading members from diverse Spanish societies and three working areas: clinical and healthcare issues, logistical and administrative issues, and economic, social, and legal issues. The recommendations outlined in this article were obtained after a comprehensive literature review and thorough discussions. This document may serve as a basis for the future development of home-administered oncologic therapy programs in Spain.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Oncology ; Home administration ; Expert recommendations ; Quality of life ; Oncology therapies
Publicat a:	Frontiers in Oncology, Vol. 14 (february 2024) , ISSN 2234-943X

DOI: 10.3389/fonc.2024.1335344
PMID: 38434688

11 p, 2.0 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats